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Abstract
Background: Human endothelial nitric oxide synthase (eNOS) requires calcium-bound calmodulin (CaM) for electron
transfer but the detailed mechanism remains unclear.
Methodology/Principal Findings: Using a series of CaM mutants with E to Q substitution at the four calcium-binding sites,
we found that single mutation at any calcium-binding site (B1Q, B2Q, B3Q and B4Q) resulted in ,2–3 fold increase in the
CaM concentration necessary for half-maximal activation (EC50) of citrulline formation, indicating that each calcium-binding
site of CaM contributed to the association between CaM and eNOS. Citrulline formation and cytochrome c reduction assays
revealed that in comparison with nNOS or iNOS, eNOS was less stringent in the requirement of calcium binding to each of
four calcium-binding sites. However, lobe-specific disruption with double mutations in calcium-binding sites either at N-
(B12Q) or at C-terminal (B34Q) lobes greatly diminished both eNOS oxygenase and reductase activities. Gel mobility shift
assay and flavin fluorescence measurement indicated that N- and C-lobes of CaM played distinct roles in regulating eNOS
catalysis; the C-terminal EF-hands in its calcium-bound form was responsible for the binding of canonical CaM-binding
domain, while N-terminal EF-hands in its calcium-bound form controlled the movement of FMN domain. Limited proteolysis
studies further demonstrated that B12Q and B34Q induced different conformational change in eNOS.
Conclusions: Our results clearly demonstrate that CaM controls eNOS electron transfer primarily through its lobe-specific
calcium binding.
Citation: Wu P-R, Kuo C-C, Yet S-F, Liou J-Y, Wu KK, et al. (2012) Lobe-Specific Calcium Binding in Calmodulin Regulates Endothelial Nitric Oxide Synthase
Activation. PLoS ONE 7(6): e39851. doi:10.1371/journal.pone.0039851
Editor: Andreas Hofmann, Griffith University, Australia
Received March 16, 2012; Accepted May 31, 2012; Published June 29, 2012
Copyright:  2012 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by the Grant of National Health Research Institutes (99A1-CSAP01-014) at Taiwan. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: 990419@nhri.org.tw (PFC); kkgo@nhri.org.tw (KKW)
Introduction
Human endothelial nitric oxide synthase (eNOS) catalyzes the
synthesis of nitric oxide (NNO), which is a key regulator of
cardiovascular homeostasis [1,2]. Like neuronal NOS (nNOS)
[3,4] and macrophage inducible NOS (iNOS) [5,6], eNOS [7] is a
homodimer; each monomer contains a C-terminal reductase
domain, and an N-terminal oxygenase domain [8–10]. The
reductase domain binds FAD and FMN cofactors, and consists of
NADPH binding site, while the oxygenase domain binds
protoporphrin IX heme, tetrahydrobiopterin (H4B), and contains
the site for L-arginine binding. These two domains are connected
by a canonical CaM-binding sequence. Binding of calcium/CaM
to this site facilitates intra-domain electron transfer between FAD
and FMN as well as inter-domain electron transfer from the flavin
of one subunit to the heme of the other subunit [11–13]. Although
the mechanism by which CaM regulates NOS activation has been
under intensive investigation, much remains unresolved. Our
recent work on eNOS has demonstrated that in addition to the
putative CaM binding domain (residues 491–510, hereafter
referred to simply as CBD) [14], two other regions, i.e. residues
174–193 of the heme-binding site and residues 729–757 located at
the hinge region connecting FAD and FMN subdomains, are
possibily involved in CaM/calcium-regulated eNOS activation
and deactivation [15]. Thus, the mechanisms underlying CaM/
calcium-dependent eNOS catalysis are more complicated than
previously thought.
CaM is a ubiquitous calcium-binding protein, structurally
resembling a dumbbell. It contains N- and C-terminal lobes
joined by a flexible helical linker [16]. Each lobe comprises two E–
F hands with two calcium-binding sites. The calcium-binding sites
in the C-terminal lobe (sites 3 and 4) have a higher affinity for
calcium than those in the N-terminal lobe (sites 1 and 2) [17].
Calcium binding triggers conformational changes of CaM,
bringing the two lobes together, forming a hydrophobic interface
to interact with its target proteins [18].
CaM regulates all three NOS isoforms. iNOS binds CaM
tightly at low calcium level and is catalytically active at basal
cellular calcium concentrations [19], while eNOS and nNOS bind
CaM reversibly in a calcium concentration-dependent manner
and require high calcium concentrations for catalysis [7,20].
Previous reports using CaM mutants with different calcium-
binding site mutations suggest differential roles of the four
calcium-binding sites for nNOS and iNOS in regulating CaM
binding and electron transfer [21–23]. The role that each calcium-
binding site plays in regulating CaM binding to eNOS and eNOS
catalytic activity is unclear. As eNOS is attached to plasma
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CaM dependent electron transfer and catalysis are likely to be
influenced by diverse signaling pathways making it more
complicated than iNOS or nNOS [24]. Furthermore, since the
calcium-binding sites of CaM can differentially regulate target
protein function, and a large fraction of free CaM is not fully
occupied with four calcium ions in fluctuating intracellular calcium
concentration [25], it is essential to clarify the role of each calcium-
binding site of CaM in eNOS activity.
Electron flow in NOS isoforms is controlled by CaM/calcium
binding. In the absence of CaM, the FMN domain is in a shielded
state (input) which is locked by NADPH binding [26] and
stabilized by the relative spatial arrangements of autoinhibitory
elements and C-terminal tail. In this state, the FMN domain is in
close contact with the FAD/NADPH binding domain [27], and
electron transfer is limited to FAD to FMN and not to other
electron acceptors. CaM/calcium binding elicits a swing of FMN
domain toward a deshielded (output) state, which facilitates
electron transfer to heme/H4B or cytochrome c [28–31]. The
N- and C-terminal lobes of CaM bind calcium ions with different
affinities and lobe-specific functions of CaM are frequently seen in
the regulation of its target proteins [32,33]. We hypothesized that
the shift of FMN subdomain from input to output states for
electron transfer depends on lobe-specific calcium/CaM binding
to eNOS. To test this hypothesis, we mutated a single calcium-
binding site (designated B1Q,B 2Q,B 3Q and B4Q, respectively),
both binding sites at N-lobe (B12Q) or C-lobe (B34Q) or all four
calcium-binding sites (B1234Q), and assessed how these mutations
impact CaM binding to CaM binding domain and CaM-mediated
eNOS conformational change, and catalytic activities.
Results
CaM mutants in eNOS activation
CaM mutants carrying various E to Q substitutions at calcium-
binding sites were generated based on the sequence of human
CaM shown in Figure 1A. Primers used to generate CaM mutants
Figure 1. CaM mutant constructs. A: The sequence of human CaM is shown, using single-letter amino acid residue codes. The mutated amino
acid residue in each calcium-binding site is marked in red. Helical regions are shown in Italics and blue color. B: The electrophoretic mobility of wild-
type and mutant CaM proteins was analyzed by SDS-PAGE. A 5-mg sample of each CaM construct was loaded in a 15% SDS-PAGE which was run with
a standard Laemmli SDS-PAGE buffer in the presence of 1 mM EGTA. Molecular masses of protein standards are shown on the left in kilodaltons (kDa).
doi:10.1371/journal.pone.0039851.g001
Table 1. The primers used for mutations and the residues
changed for each mutant.
Mutants Primers
Residue
changed
B1Q 59-CACCACCAAGCAATTGGGGACAGTGAT-39 E31–Q31
59-ATCACTGTCCCCAATTGCTTGGTGGTG-39
B2Q 59-CTTCCCGCAGTTCTTAACCATGATG-39 E67–Q67
59-CATCATGGTTAAGAACTGCGGGAAG-3
B3Q 59-CTACATCAGCGCTGCGCAGCTGCGT-39 E104–Q104
59-ACGCAGCTGCGC AGCGCTGATGTAG-39
B4Q 59-GGCCAGGTTAACTATGAACAGTTTGTA-39 E140–Q140
59-TACAAACTGTTCATAGTTAACCTGGCC-39
B12Q E31–Q31
E67–Q67
B34Q E104–Q104
E140–Q140
B1234Q E31–Q31
E67–Q67
E104–Q104
E140–Q140
doi:10.1371/journal.pone.0039851.t001
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Purified CaM mutants were at least 95% pure with an estimated
molecular mass of ,17 kDa based on SDS-PAGE analysis, which
was run in a standard SDS-PAGE buffer containing 1 mM
EGTA. We generally obtained about 16 to 100 mg purified
proteins from a liter of culture medium. The electrophoretic
mobility of most mutants was not obviously different from that of
the wild-type CaM, with the exception of B4Q mutant which had
slightly higher mobility (Figure 1B).
The steady-state citrulline formation was used to determine
electron flux from NADPH to the heme of oxygenase domain.
Effects of wild-type and mutant CaMs on citrulline formation was
evaluated by adding increasing concentrations of CaM to the assay
mixture. Concentration response curves for wild-type CaM and
each mutant are shown in Figure 2. Compared to wild-type CaM,
B1234Q showed no activation at all while B12Q and B34Q greatly
diminished ability to activate citrulline formation through their
wide-ranging concentrations. The response curves of the four
single-site mutants (B1Q,B 2Q,B 3Q, and B4Q) resembled the wild-
type response curve. Quantitative analysis from multiple experi-
ments revealed that the EC50 (concentration required for half
maximal citrulline formation) for the single-site mutants is about
2–3 fold higher than that of wild-type (Table 2). These data
suggest that each of the four calcium-binding sites supports the
association between CaM and eNOS (Table 2).
As CaM concentrations increased, some mutants exhibited
citrulline forming activity even higher than wild-type CaM. We
compared the citrulline formation in the presence of saturating
concentrations for each CaM construct (0.5 mM), and activity
obtained with eNOS bound to wild-type CaM was set to 100%. As
shown in Figure 3A, the wild-type CaM increased citrulline
formation ,50-fold above that observed in the absence of CaM.
Maximal citrulline formation with B1Q was reduced by 25% and
B2Q was not significantly different from the wild-type (Figure 3A),
while maximal citrulline formation of B3Q and B4Q was slightly
higher than that of the wild-type. Of the two double mutants, the
extent of maximal activity with B12Q and B34Q was reduced to
24% and 18% of the wild-type, respectively. The activity with
B1234Q was not increased and remained at the level without CaM
(Figure 3A). The result indicates that except for B1Q, single
mutation at calcium-binding site of CaM has little effect on eNOS
citrulline forming activity while disruption in two calcium-binding
sites either at N- (B12Q) or at C-terminal (B34Q) lobe greatly
impacts eNOS oxygenase activity.
We next evaluated the effect of CaM mutants on eNOS
reductase activity. Cytochrome c accepts electrons exclusively from
the FMN domain and has been used to measure electron flow
within the reductase domain. Binding of wild-type CaM to eNOS
induced a ,4-fold increase in cytochrome c reduction. B3Q mutant
increased cytochrome c reduction to a level comparable to wild-type
CaM (Figure 3B). On the other hand, cytochrome c reduction
induced by B1Q,B 2Q and B4Q was 63%, 67% and 55% of the
wild-type level, respectively. The multiple mutants, i.e. B12Q,B 34Q
and B1234Q exhibited slight or no increase in cytochrome c reductase
activity. These results demonstrate that with the exception of B3Q,
single mutation at calcium-binding sites in CaM affects the
reductase activity greater than the oxygenase activity in eNOS.
Furthermore, full calcium bindings at N- and C-terminal lobes are
essential for electron transfer through the eNOS reductase domain
(Figure 3B).
Binding of CaM mutants to eNOS CaM binding domain
(CBD) Peptide
The ability of various CaM mutants to bind CBD was
evaluated. Each CaM mutant was incubated with CBD in the
presence of 100 mM calcium at several different peptide:CaM
ratios. The CBD-CaM complexes and free CaM were examined
by nonreducing, nondenaturing electrophoresis. Free peptides
were not detected because they are positively charged at neutral
pH and therefore will have an upward mobility toward cathode
and do not enter the gel [34,35]. In the presence of EGTA, no
mobility shift bands were detected for wild-type or any CaM
mutant (data not shown). Peptide-CaM complexes can be seen
above free CaM band in the presence of 100 mM calcium. The
extent of CaM-peptide interaction is assessed by measuring
attenuation of free CaM bands and the shift in the mobility of
the CaM protein with increasing peptide concentration. As shown
in Figure 4, B1Q,B 2Q and B3Q bound CBD with an affinity similar
to the wild-type CaM. B4Q and B12Q bound CBD but the binding
was not complete. B34Q and B1234Q did not bind CBD. These
results suggest that the canonical CaM-binding site on eNOS
interacts with the calcium-bound C-lobe in CaM.
Figure 2. Citrulline formation as a function of CaM concentra-
tions. Citrulline forming activity was determined in a reaction mixture
containing 25 mM Tris, pH 7.5, 100 nM eNOS, 3H-L-arginine (1mCi), L-
arginine (20 mM), NADPH (100mM), H4B (10mM), and CaCl2 (300 mM),
0.2 mM EDTA, 100 mM NaCl, 0.1 mM DTT, 10% glycerol and the
indicated concentration of each CaM construct as described under
Experimental Procedures. Data are mean of duplicate measurements
with ,5% variation. Each experiment was repeated three times.
doi:10.1371/journal.pone.0039851.g002
Table 2. The EC50 for each CaM construct in activation of
eNOS citrulline formation.
Mutants EC50 (nM)
WTCaM 75610
B1Q 161614
B2Q 125612
B3Q 170616
B4Q 14868
The bar values represent the means 6 standard deviation. The mean values
were obtained from three independently prepared batches of proteins.
doi:10.1371/journal.pone.0039851.t002
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Flavin Fluorescence
Since the N- and C-terminal lobes of CaM can function as an
independent domain [33,36], we determined whether a conver-
sion of the FMN subdomain from shielded to deshielded state
depends on calcium-bound N- and C-terminal lobes of CaM. As
the intensity of flavin fluorescence is proportional to the degree of
FMN deshielding [37], we monitored the change in flavin
fluorescence of eNOS induced by wild-type CaM, B12Q or B34Q
in the presence or absence of calcium. As shown in Figure 5A,
wild-type and mutant CaMs were unable to increase flavin
fluorescence of eNOS in the presence of 2 mM EGTA. Upon
addition of calcium, B34Q increased flavin fluorescence intensity to
the same level as the wild-type CaM. In contrast, B12Q increased
much less fluorescence intensity compared with wild-type CaM or
B34Q, indicating that the N-terminal EF-hands in its calcium-
bound form are responsible for the input/output swing of FMN
domain (Figure 5B).
Trypsinolysis of eNOS in the presence of wild-type CaM,
B12Q or B34Q
As the results shown above have provided evidence that CaM
N- and C-terminal lobes in its calcium-bound form play distinct
roles in interacting with CaM binding domain and in the shift of
input/output state of FMN domain, we speculated that binding of
these two lobes might induce different conformational changes in
eNOS. We used limited trypsin digestion to detect the eNOS
conformation changes induced by wild-type vs. B12Q or B34Q.
Limited trypsinolysis of eNOS was carried out in the presence of
high or low calcium concentrations.
In the absence of calcium, trypsinolysis of eNOS incubated with
wild-type, B12Q or B34Q produced an identical fragment profile
with one major band having apparent molecular mass of , 56
kDa. N-terminal sequencing revealed that this band was composed
of two portions of N-terminal sequences of K
29QGPA (fragment-
1a in Figure 6A) and K
498EVAN (fragment-2a in Figure 6A),
indicating two cleavage sites: (1) between Lys28 and Gln29 and (2)
between Lys497 and Glu498. Lys28 is close to the palmitoylation
site, and Lys497 is within the canonical CaM-binding domain of
eNOS (Figure 6C), reflecting that without CaM protection, CaM-
binding domain of eNOS is sensitive to trypsin digestion.
In the presence of calcium, trypsin digestion of eNOS with wild-
type CaM yielded three notable bands ,67 kDa (fragment-1b),
,58 kDa (fragment-2b) and ,52 kDa(fragment-4b & 5b)
(Figure 6B). N-terminal sequencing of ,67 kDa band revealed
the cleavage site at K
29QGPA and judged from the apparent size,
the C-terminal tryptic site is probably around Arg630 which is
situated in the autoinhibitory (AI) region (Figure 6C, fragment-1b),
consistent with the previous report that calcium/CaM binding
induces eNOS conformational change resulting in the exposure of
the autoinhibitory elements [38]. N-terminal sequencing of the
,58-kDa band showed the cleavage site at K
29QGPA and C-
terminal tryptic residue at approximately 549, based on size
estimate (fragment-2b in Figure 6C). N-terminal sequencing of
,52 kDa band revealed two N-terminal sequences: (1) fragment-
4b with N-terminal sequence of R
722DIFS and an estimated C-
terminal end at residue 1203, and (2) fragment-5b with N-terminal
sequence of K
517RVKA and an estimated C-terminal end at
residue 994 (Figure 6C).
Trypsin digestion of eNOS with B12Q produced a similar
fragment profile as that with wild-type CaM, except that a portion
of N-terminal sequence of fragment-3b was not detected in wild-
type CaM and fragment 5b was not detected in B12Q (Figure 6B).
The N-terminal sequence of fragment-3b is K
498EVAN that is
within canonical CaM-binding domain at eNOS (Figure 6C). By
contrast, the fragment profile of eNOS trypsinolysis with B34Q
revealed an attenuated fragment-1b and enhanced fragment-2b
and 3b as well as fragments 4b and 5b. The trypsinolysis data
provide important insights into the influence of CaM on eNOS
conformation: (1) Cleavage of eNOS at Lys28 was observed either
in the presence or absence of CaM, indicating that the sequence at
this residue near the palmitoylation site is in an exposed area. The
eNOS is dually acylated by N-myristoylation at Gly2 and by
thiopalmitoylations at Cys15 and Cys26 [39,40]. As palmitoylation
is reversible, whether existence of regulated cycles of palmitoyla-
tion and depalmitoylation controls eNOS degradation remains
further investigation; (2) N-terminal sequence of K
498EVAN
(fragment-3b) was detected with B12Q and B34Q but not with
wild-type CaM; the intensity of fragment-3b in B12Q was weaker
than in B34Q. This is consistent with the gel mobility shift assay, in
which B12Q binds CaM binding domain but not as well as wild-
type CaM; B34Q shows no binding at all. The result further
confirms that C-terminal lobe in its calcium-bound form can
Figure 3. Ability of various CaM mutants to activate eNOS
enzymes. A: Citrulline formation activity. B: Cytochrome c reduction
activity. Both citrulline formation and cytochrome c reduction were
measured in the presence of saturating concentration of each CaM
construct (0.5 mM). NOS activities were expressed as percentage of the
respective maximal NOS activity (100%) which was obtained with the
eNOS bound to wild-type CaM. Under these conditions, the activities for
eNOS bound to wild-type CaM were ,14 min
21 for citrulline formation,
and ,286 min
21 for cytochrome c reduction. Data are presented as
means6standard deviation. * denotes p,0.05, ** ,0.01, NS, not
significant difference as compared to wild-type CaM. Each experiment
was performed in triplicate and repeated three times.
doi:10.1371/journal.pone.0039851.g003
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491–510) was incubated with CaM constructs (200 pmol) by increasing peptide:CaM molar ratios at room temperature for 1 h before electrophoresis
in the presence of 100 mM of calcium. The samples were analyzed on 18% non-denaturing gels and visualized with Coomassie Blue R-250. The first
lane in each gel contains CaM only, i.e. CBD/CaM ratio is 0. The rest CBD/CaM ratios were indicated. CBD-CaM complexes and free CaM are denoted.
doi:10.1371/journal.pone.0039851.g004
Figure 5. Flavin fluorescence of eNOS treated with wild-type and CaM mutants. A: Fluorescence emission spectra of eNOS were obtained
in a solution containing 25 mM Tris, pH 7.5, 100 mM NaCl, 0.1 mM DTT, ,6 mM eNOS and ,12mM of wild-type CaM, B12Q or B34Q in the presence of
2 mM EGTA. B: The change of fluorescence intensity for wild-type CaM, B12Q or B34Q was recorded upon addition of 2.5 mM CaCl2 to the above
mixtures. Excitation wavelength was set at 455 nm. The fluorescence data were corrected by subtracting CaM and buffer effects. The eNOS alone and
eNOS-CaM complex are indicated in each plot.
doi:10.1371/journal.pone.0039851.g005
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binding of eNOS by wild-type, B12Q or B34Q similarly resulted in
the exposure of R
722DIFS to trypsin digestion. This sequence is
situated at the hinge region between FMN and FAD domains
(Figure 6C). Our previous finding has suggested that this region
may interact with CaM and is involved in eNOS catalysis [15].
That binding of wild-type or CaM mutants impaired in calcium-
binding at C- or N-lobe caused a similar exposure of the hinge
region, suggests highly flexible nature of this region, which is likely
to serve as a pivot for the motion of FMN domain [41]; (4)
Figure 6. Limited trypsinolysis of eNOS in the presence of wild-type CaM, B12Q or B34Q. A: Trypsinolysis of eNOS (,5mM) was performed in
the presence of 10 mM of wild-type CaM, B12Q or B34Q at 22uC for 15 min with 1 mM EGTA. B: Trypsinolysis was carried out in the presence of 100 mM
CaCl2. Lane 1: undigested eNOS with wild-type CaM; lane 2: trypsinized eNOS with wild-type CaM; lane 3: undigested eNOS with B12Q; lane 4:
trypsinized eNOS with B12Q; lane 5: undigested eNOS with B34Q; lane 6: trypsinized eNOS with B34Q. Molecular masses of marker proteins are shown
on the left in kilodaltons (kDa). Following SDS-PAGE, the tryptic samples were transferred to PVDF membranes using CAPS buffer for 3 h at 50 V and
4uC. The bands excised for N-terminal sequencing are indicated. C: Relative position of N-terminal sequences of the indicated tryptic fragments in the
schematic eNOS structure. The C-terminal termination sites are unknown and the residue at C-terminal end in each tryptic fragment was
approximately estimated from the apparent molecular mass. Red arrow depicts the tryptic cleavage site. The blocks indicate binding sites for heme,
H4B, CaM, FMN, FAD and NADPH. AI and CT refer to autoinhibitory loop and C-terminal tail, respectively. The myristoylation site (Myr.) and
palmitoylation sites (Palm.) are denoted.
doi:10.1371/journal.pone.0039851.g006
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517RVKA (fragment-5b) with wild-type and B34Q
binding but not B12Q binding suggests that binding of CaM N-
terminal lobe in calcium-bound form exposes Arg517 for trypsin
digestion. eNOS Arg517 is analogous to iNOS Arg536 and nNOS
Arg757 which are reported to form both salt bridge and hydrogen
bonding interaction with CaM Glu47 and several backbone
oxygens in NOS FMN subdomain [42], and are considered to be
crucial for control of FMN subdomain interactions with its redox
partners [43].
Discussion
The results indicate that each calcium-binding site on CaM
plays a part in mediating CaM-induced eNOS electron transfer
and catalytic activity. Single mutation of each binding site results
in an increased EC50 by ,2–3 fold over the wild-type without a
substantial effect on maximal citrulline formation. However,
double mutation of binding sites at the C-lobe or N-lobe of
CaM drastically reduces maximal citrulline formation and
cytochrome c reduction, indicating requirements of lobe-specific
calcium binding for eNOS reductase and oxygenase activities. Gel
mobility shift assay, flavin fluorescence measurements and limited
trypsinolysis demonstrate that the N- and C-terminal lobes play a
distinct role in eNOS activation, i.e. N-lobe in its calcium-bound
form controls FMN subdomain motion, while C-lobe in its
calcium-bound form binds CaM binding domain region in eNOS.
Taken together the results from our current study, we outlined
these findings in a schematic diagram based upon NOS dimeric
model from Daff [44] and CaM bi-lobed structure from Rodney
et al. [45], illustrating how N- and C-terminal lobes of CaM
differentially regulate eNOS catalysis (Figure 7). In the absence of
calcium, apo-CaM is not associated with eNOS in which Lys497 is
sensitive to trypsin digestion; the FMN domain, closely associated
with FAD domain, is in the locked position and electron flux is
blocked (Figure 7A). Upon calcium binding, wild-type CaM
undergoes a conformational change; wraps around the CaM-
binding domain and potentially other CaM-binding sites in eNOS
with its two lobes bound, as has been proposed for the multiple
Figure 7. Schematic illustration of differential regulation of eNOS electron transfer by N- and C-terminal lobes of CaM. Dimeric eNOS
model is derived from Daff [44]. The gray colored domains represent one subunit, and the sky-blue colored domains represent the other. The blocks
indicate binding sites for heme, H4B, zinc, CaM, FMN, FAD and NADPH. The canonical CaM-binding domain (residues 491–510) between the FMN
domain and the heme domain is denoted as CBD. CaM shown as two lobed structures N and C, joined by a flexible linker is adapted from Ref 45;
apoCaM is marked with white circles and calcium binding is indicated by yellow circles. A: In the absence of calcium, apo-CaM is not associated with
eNOS in which Lys497 is exposed to the trypsin digestion; the FMN domain is locked with FAD domain and electron flux is blocked. B: Upon calcium
binding, wild-type CaM wraps around the eNOS CBD and potentially other sites with its two lobes bound. This binding protects Lys497 from tryptic
cleavage and exposes Arg517 for trypsinolysis. Consequently, the FMN domain is released from the FAD domain, becoming accessible to the heme
domain of the opposite subunit. C: With B12Q mutation of N-lobe, calcium-bound C-lobe binds normally to CBD while the mutated N-lobe could not
bind calcium and is unable to bring FMN domain to the heme domain of the other subunit which hinders electron transfer as illustrated by a dotted
line. D: With B34Q mutation of C-lobe, C-lobe is unable to bind CBD which retards electron transfer.
doi:10.1371/journal.pone.0039851.g007
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Lys497 from tryptic cleavage and exposes Arg517 for trypsinolysis.
Consequently, the FMN domain is released from the closed to the
open position, becoming accessible to the heme domain of the
opposite subunit or to an exogenous electron acceptor like
cytochrome c (Figure 7B). With B12Q double mutation of N-lobe,
CaM is tethered to the N-terminus of eNOS CaM-binding domain
solely by calcium- bound C-lobe. This association protects Lys497
from tryptic cleavage with slight induction of the FMN domain
mobility. In this state, the FMN domain is mainly in the locked
position, resulting in great attenuation of eNOS activity.
(Figure 7C). With B34Q double mutation of C-lobe, calcium-
bound N-lobe is unable to protect Lys497 from tryptic cleavage
but exposes Arg517 for trypsinolysis and increases flavin fluores-
cence to the same level as wild-type CaM. This implies that B34Q
does not bind to CaM-binding domain but rather to a region
adjacent to CaM-binding domain. In this state, although the FMN
domain is in the open position, both eNOS oxygenase and
reductase activities are greatly attenuated, indicating that the
released FMN domain no longer associates with its redox partners
as it normally would (Figure 7D). This clearly shows that binding
between CaM and CaM-binding domain of eNOS is head-to-tail
with the C-lobe of CaM bound to the N-portion of CaM-binding
domain. Lobe-specific calcium binding is crucial for CaM to
control eNOS electron transfer, and efficient activation requires
both CaM N- and C-terminal lobes in its calcium-bound form to
interact with CaM-binding domain as well as with other CaM-
binding elements in eNOS.
Comparison of the calcium-binding site mutations on citrulline
formation and cytochrome c reduction in eNOS vs. the other
isoforms reveal significant differences. As shown in Table 3, single
calcium-binding site mutation of CaM exerts effect on eNOS
activation less than on nNOS or iNOS. Notably, B1Q mutant
reduced eNOS citrulline formation by 25% but completely
abolished nNOS citrulline formation [21] and conversely did not
influence iNOS citrulline formation [22]. On the other hand, B3Q
mutant which did not affect eNOS and caused a mild reduction of
nNOS citrulline formation reduced iNOS citrulline formation by
.50% while B4Q which increased eNOS citrulline formation
caused a profound reduction of nNOS but had little effect on
iNOS citrulline formation. B2Q did not significantly influence
eNOS citrulline formation but exerted a great effect on nNOS and
iNOS citrulline formation. B3Q selectively reduced iNOS citrulline
formation whereas B4Q reduced nNOS citrulline formation. The
effect of a single site mutation on cytochrome c reduction is
concordant with that on citrulline formation with the exception of
B4Q which reduces cytocrome c reduction without a significant
effect on citrulline formation. Our data reveal that lobe-specific
mutation of calcium-binding sites (B12Q and B34Q alike) severely
interferes with eNOS and nNOS activity without an effect on
iNOS (23). These results provide evidence for differential effects of
CaM calcium-binding status on electron flow and catalytic activity
in eNOS vs. nNOS and iNOS.
B4Q in comparison with wild-type CaM attenuated cytochrome c
reduction by ,45% while it increased citrulline formation
(Figure 3B vs. 3A). This differential effect is unexpected as the
crystallographic analysis of CaM bound to eNOS CaM-binding
domain [14] or nNOS CaM-binding domain as well as CaM-
iNOS FMN subdomain complex [42] has shown interaction of
CaM with the canonical CaM-binding site of all three NOS
isoforms in an anti-parallel orientation in which the B4Q site (E140
of CaM) interacts with the N-terminal portion of CaM-binding
domain situated in the vicinity NOS oxygenase domain. It is
unclear how mutation of this site only affects reductase activity
without reducing oxygenase activity. The results nevertheless
support the notion that CaM activates reductase and oxygenase by
distinct mechanisms [46].
A recent crystal structure of a CaM-bound iNOS FMN
subdomain [42] has shown that Glu47 located at the CaM N-
terminal lobe participates in a bridging interaction with the iNOS
FMN domain that helps transduce the effects of bound CaM. The
authors suggested that an analogous CaM-FMN subdomain
bridging interaction be expected to be present in the nNOS and
eNOS enzymes. Tejero et al. later proved that this bridging
connection appeared to control nNOS FMN subdomain move-
ment [43]. Here, we propose that this bridging interaction is
primarily controlled by lobe-specific calcium binding in CaM. Our
flavin fluorescence data demonstrate that B34Q is able to induce
eNOS fluorescence intensity to the same level as the wild-type
CaM, suggesting an interaction between CaM Glu47 and eNOS
FMN subdomain which is present in an output state. However,
B34Q hardly increases eNOS oxygenase and reductase activities,
possibly due to defective binding to CaM-binding domain. These
data imply that attachment of calcium-bound C-terminal lobe of
CaM to eNOS CaM-binding domain triggers FMN domain to be
in a more suitable orientation for interacting with its redox
partners. As B12Q induced a much smaller increase in flavin
fluorescence than wild-type CaM, it is possible that the bridging
interaction between CaM Glu47 and eNOS FMN subdomain
requires CaM N-terminal lobe in its calcium-bound form. From
these findings, we conclude that calcium-bound C-lobe and N-lobe
of CaM interact with eNOS at different regions in a coordinated
manner that is necessary for the efficient electron transfer among
different redox centers in eNOS.
Materials and Methods
Materials
L-[2,3,4,5
23H] arginine (NET1123250UC) was obtained from
PerkinElmer Inc. (6R)-5,6,7,8,-Tetrahydro-L-biopterin (H4B) was
Table 3. Differential effect of mutating Ca
2+-binding sites at
CaM on enzyme activation among NOS isoforms.
Cyto c Reduction
Citrulline formation or NO
production
eNOS nNOS iNOS eNOS nNOS iNOS
CaMs (%) (%)
None 3064
a 4.2
b 2.860.8
a 0.47
b
WT 100612
a 100
b 100
c 10062
a 100
b 100
c
B1Q 6367
a 11
b 109
c 7564
a ,2
b 95
c
B2Q 6766
a ,50
b 64
c 9466
a 26
b 41
c
B3Q 99611
a 76
b 67.7
c 10569
a 82
b 43
c
B4Q 5567
a ,53
b 42.8
c 111613
a 30
b 90
c
B12Q 3464
a ,6
d 140
d 2466
a ,5
d 75
d
B34Q 3865
a ,12
d 100
d 1865
a ,10
d 115
d
B1234Q 2763
a ,11
d ,25
d 2.360.4
a ,2
d ,25
d
aThis manuscript: The activity was obtained in the presence of 0.5 mM CaM
concentration. Under these conditions, the activities for eNOS bound to wild-
type CaM were ,14 min
21 min
21 for citrulline formation, and ,286 min
21 for
cytochrome c reduction.
bData from Ref. 21.
cData from Ref. 22.
dData from Ref. 23.
doi:10.1371/journal.pone.0039851.t003
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protein dye reagent and electrophoretic chemicals were products
of Bio-Rad. Restriction enzymes were from New Englands
Biolabs. CaM-agarose, AG 50W-X8 (cation-exchange resin),
NADPH and other reagents were obtained from Sigma. Sf21
insect cell was obtained from Clontech (ordering number 631411).
Mutagenesis
The human CaM cDNA was generously provided by Dr.
Emanuel E Strehler. A series of single-point mutants of human
CaM with Glu (E) to Gln (Q) substitutions at the z positions for
coordinating calcium in each EF-hand, were generated by site-
directed mutagenesis and termed as B1Q (E31Q), B2Q (E67Q), B3Q
(E104Q) and B4Q (E140Q), respectively. Multiple point mutants
unable to bind calcium either at the N-terminal lobe (B12Q; E31Q
and E67Q mutations), the C-terminal lobe (B34Q; E104Q and
E140Q mutations) or both lobes (B1234Q; E31Q, E67Q, E104Q
and E140Q) were subsequently prepared. The basic strategy for
PCR-based mutagenesis was described previously [47]. The
primers used for mutation and the residues changed for each
mutant are listed in Table 1. The mutated residues glutamine
(CAA or CAG) are highlighted with boldface. All primers were
synthesized by MdBio Inc. (Taipei, Taiwan). Wild-type and
mutant CaMs were cloned into pT7-7 vector through the NdeI
and HindIII sites. The correct mutations were confirmed by
Sequencing Service in the core facility of NHRI at Miaoli,
Taiwan. The sequenced CaM genes were same as Genbank under
accession number J04046.
Expression and Purification of Wild-type and Mutant
CaMs
BL21 (DE3) transformed with each CaM construct were grown
at 37uC in LB medium supplemented with 100 mg/ml ampicillin.
The cultures were induced by 0.3 mM isopropy-b-D-thiogalacto-
pyranoside when the OD600 reached to 0.8– 1.2 and harvested
after overnight expression at room temperature. Purification of
various CaMs was carried out essentially as described previously
[15,48]. The CaM concentration was determined either by
Bradford method [49] or spectrophotometry using C - 277 nm
=2560 M
21 cm
21.
Expression and Purification of eNOS
Human eNOS cDNA were inserted into EcoRI site of pVL1392
transfer vector, which was used to generate recombinant viruses in
Sf21/baculovirus system. Due to low heme biosynthetic capability
of Sf21 cells, supplemental heme chloride (4mg/ml) was added into
the culture medium 18 h postinfection to enrich heme content of
the expressed eNOS. Cells were harvested 60 h postinfection,
suspended in buffer containing 25 mM Tris-HCl, pH 7.5,
0.2 mM dithiothreitol (DTT), 0.1 mM EDTA, 0.1 mM EGTA,
1 mM pepstatin A, 1mM leupeptin, 1 mM antipain, 1 mM
phenylmethylsulfonyl fluoride, and 10% glycerol, and then
sonicated 20 s for three times, centrifuged twice at 30,0006g for
20 min at 4uC. The supernatant was loaded onto a 29,5 9-ADP-
Sepharose affinity column (1.565 cm), proteins were eluted with a
buffer containing 25 mM Tris-HCl, pH 7.5, 0.1 mM DTT,
20 mM 29&39-AMP mixture, 0.5 M NaCl and 10% glycerol.
The eluate was diluted with 4-volume buffer containing 25 mM
Tris-HCl, pH 7.5, 0.1 mM DTT, 100 mM CaCl2 and 10%
glycerol, and applied to a CaM-agarose column(1.565 cm) pre-
equilibrated with buffer containing 25 mM Tris-HCl, pH 7.5,
0.1 mM DTT, 100 mM CaCl2, 100 mM NaCl and 10% glycerol
(Buffer A). The column was washed with Buffer A and eluted with
buffer containing 25 mM Tris-HCl, pH 7.5, 0.1 mM DTT,
2 mM EGTA, 0.5M NaCl and 10% glycerol. The eluate was
concentrated by Centriprep-50 (Millipore) and dialyzed against
buffer containing 25 mM Tris-HCl, pH 7.5, 0.1 mM DTT,
100 mM NaCl and 10% glycerol.
Steady-state eNOS Activity
eNOS activity was determined by measuring conversion of L-
[3H] arginine to L-[3H] citrulline as previously described [4] with
slight modifications. The reaction mixture containing 25 mM
Tris-HCl, pH 7.5, 0.1 mM DTT, 100 nM eNOS, 300 mM CaCl2,
0.2 mM EDTA, 100 mM b-NADPH, 10 mMH 4B, 20 mML -
arginine, 10% glycerol, and 1mCi of L-[
3H] arginine was
incubated at 37uC for 4 min either with a fixed amount
(0.5 mM) or various concentrations of each CaM construct.
Cytochrome c reduction was determined at room temperature in a
reaction mixture containing 25 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 10% glycerol, 50 mM cytochrome c, 0.5 mM CaM, 100 mM
CaCl2, and 100 mM b-NADPH. The reaction was initiated by
addition of 50 nM eNOS and monitored at 550 nm in a GE
geneQuant100 spectrophotometer. Activity was determined using
a C - red-oxi of 21 mM
21cm
21.
Gel mobility-shift assay
A canonical CaM-binding peptide (CBD), TRKKTFKEVA-
NAVKISASLM (eNOS residues 491–510) was synthesized by
Peptide 2, Inc. (Chantilly, VA). Each CaM construct (200 pmol)
was incubated with CBD at increasing molar ratios for 1 h at room
temperature in a buffer (10 ml) containing 20 mM Tris, pH 7.5
with either 100 mM CaCl2 or 1mM EGTA. The sample was
subjected to 18% nondenaturing, non-reducing PAGE [50], which
was run at 30 mA under high calcium conditions (100 mM free
calcium in gel buffers) or low calcium conditions (1mM EGTA in
gel buffers). Binding of CBD to CaM was visualized by Coomassie
blue R-250 staining.
Fluorescence Spectroscopy
The steady-state flavin fluorescence was measured in a solution
containing 25 mM Tris, pH 7.5, 100 mM NaCl, 0.1 mM DTT,
2 mM EGTA, 10% glycerol, and ,6 mM eNOS in the absence or
presence of ,12 mM of CaM constructs using a VARIAN CARY
Eclipse fluorescence spectrophotometer. A 1-ml quartz cuvette
with a path length of 1 cm was used for the experiments. The total
volume change was kept less than 0.3%, and the samples were
maintained at room temperature during measurement. The effect
of wild-type and mutant CaM binding on the eNOS flavin
fluorescence was monitored upon addition of 2.5 mM CaCl2. The
protein was excited at 455 nm and emission spectra were recorded
between 460 to 700 nm within 5 min for each sample. Emission
spectra were corrected for background due to the buffer and CaM
effects.
Trypsinolysis of eNOS
Limited proteolysis was carried out in a mixture containing
5 mM of recombinant eNOS purified from Sf21 cells, 50 mM Tris,
pH 7.5, 100 mM NaCl, 10 mM of wild-type or mutant CaM, and
either in the presence of 100 mM CaCl2 or 1mM EGTA. Samples
were preincubated at room temperature for 15 min, and
proteolysis was initiated by addition of 0.1 ng of Trypsin Gold
(Promega) per pmol of eNOS. Following incubation at room
temperature for 15 min, the reaction was terminated by boiling
with an equal volume of 2X SDS gel-loading buffer. Proteolytic
Lobe-Specific Regulation of CaM in eNOS Activity
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and visualized by staining with Coomassie Blue R250.
N-terminal sequence analysis
Following SDS-PAGE, the tryptic samples were transferred to
polyvinylidene difluoride (PVDF) membranes using CAPS buffer
for 3 h at 50 V and 4uC. The bands were stained with Ponceau red
and excised for sequencing. Sequencing was performed on an
Applied Biosystems Model 494 protein sequencer at Mission
Biotech Inc. (Taipei, Taiwan).
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